Merck & Co Inc. (1987) Fact sheet—Merck Mectizan Donation Program—river blindness (onchocerciasis). MCT-2007-PA-003-BK. Accessed: August 6, 2014.
[2]
Sturchio JL, Colatrella BD. (2002) 14 successful public-private partnerships in global health: lessons from the Mectizan Donation Program. In: Granville B, editor. The Economics of Essential Medicines. London: Royal Institute of International Affairs. pp. 255–274.
[3]
Dull HB. (1990) Mectizan donation and the Mectizan Expert Committee. Acta Leiden 59: 399–403. pmid:2378222
[4]
World Health Organization. (1996) Community directed treatment with ivermectin: report of the multi-country study. TDR/AFR/RP/96.1. (5/22/2013).
[5]
Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, et al. (2002) APOC's strategy of community-directed treatment with ivermectin (CDTi) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control. Ann Trop Med Parasitol 96 Suppl 1: S93–104. pmid:12081254 doi: 10.1179/000349802125000673
[6]
World Health Organization. (2012) African Programme for Onchocerciasis Control: meeting of national onchocerciasis task forces, September 2012. Wkly Epidemiol Rec 87: 494–502. pmid:23311005
[7]
Ngoumou P, Walsh JF, Mace JM. (1994) A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol 88: 463–474. pmid:7979636
[8]
Alexander ND, Cousens SN, Yahaya H, Abiose A, Jones BR. (1993) Ivermectin dose assessment without weighing scales. Bull World Health Organ 71: 361–366. pmid:8324855
[9]
Thylefors B, Alleman MM, Twum-Danso NA. (2008) Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis. Trop Med Int Health 13: 689–696. doi: 10.1111/j.1365-3156.2008.02049.x. pmid:18419585
[10]
Kamgno J, Boussinesq M, Labrousse F, Nkegoum B, Thylefors B, et al. (2008) Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp. Am J Trop Med Hyg 78: 546–551. pmid:18385346
[11]
Addiss DG, Rheingans R, Twum-Danso NA, Richards FO. (2003) A Framework for Decision-Making for Mass Distribution of Mectizan in Areas Endemic for Loa loa. Filaria J 2 Suppl 1: S9. pmid:14975066 doi: 10.1186/1475-2883-2-s1-s9
[12]
World Health Organization. (2012) Progress towards eliminating onchocerciasis in the WHO Region of the Americas in 2011: interruption of transmission in Guatemala and Mexico. Wkly Epidemiol Rec 87: 309–314. pmid:22905372
[13]
Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, et al. (2012) Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis 6: e1825. doi: 10.1371/journal.pntd.0001825. pmid:23029586
[14]
Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, et al. (2009) Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3: e497. doi: 10.1371/journal.pntd.0000497. pmid:19621091
[15]
Prichard RK, Basanez MG, Boatin BA, McCarthy JS, Garcia HH, et al. (2012) A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 6: e1549. doi: 10.1371/journal.pntd.0001549. pmid:22545163
[16]
Boatin BA, Basanez MG, Prichard RK, Awadzi K, Barakat RM, et al. (2012) A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis 6: e1547. doi: 10.1371/journal.pntd.0001547. pmid:22545161
